A new blood test for diagnosing Alzheimer's disease could be available within the next five years.
Researchers from the National University of Singapore (NUS) have come up with a test known as amplified plasmonic exosome (Apex) that can detect a molecule that indicates early-stage Alzheimer's disease, the most common cause of severe dementia.
The test is the first of its kind in the world and could potentially be used to diagnose the disease before clinical symptoms appear, said Dr Shao Huilin of the NUS Institute for Health Innovation & Technology (NUS iHealthtech).
Read More: https://www.tnp.sg/news/singapore/nus-scientists-develop-blood-test-alzheimers